These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17260122)

  • 1. Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells.
    Isomoto S; Hattori K; Ohgushi H; Nakajima H; Tanaka Y; Takakura Y
    J Orthop Sci; 2007 Jan; 12(1):83-8. PubMed ID: 17260122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteoblastic differentiation and in vivo osteogenic activity of marrow-derived mesenchymal stem cells stimulated by Tacrolimus: experiment with rats].
    Dong J; Dai WD; Fang TL; Lin H; Uemura T
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):190-4. PubMed ID: 17425851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenic differentiation of rat mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells: melatonin as a differentiation factor.
    Zaminy A; Ragerdi Kashani I; Barbarestani M; Hedayatpour A; Mahmoudi R; Farzaneh Nejad A
    Iran Biomed J; 2008 Jul; 12(3):133-41. PubMed ID: 18762816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene: its ossification-promoting effect on female mesenchymal stem cells.
    Matsumori H; Hattori K; Ohgushi H; Dohi Y; Ueda Y; Shigematsu H; Satoh N; Yajima H; Takakura Y
    J Orthop Sci; 2009 Sep; 14(5):640-5. PubMed ID: 19802678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of purmorphamine and sirolimus on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.
    Faghihi F; Baghaban Eslaminejad M; Nekookar A; Najar M; Salekdeh GH
    Biomed Pharmacother; 2013 Feb; 67(1):31-8. PubMed ID: 23228449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo.
    Yoshikawa T; Nakajima H; Yamada E; Akahane M; Dohi Y; Ohgushi H; Tamai S; Ichijima K
    J Bone Miner Res; 2000 Jun; 15(6):1147-57. PubMed ID: 10841184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of osteogenic activity in mesenchymal stem cells by FK506.
    Dai W; Dong J; Fang T; Uemura T
    J Biomed Mater Res A; 2008 Jul; 86(1):235-43. PubMed ID: 18080300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
    Guang LG; Boskey AL; Zhu W
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 enhanced osteoblastic differentiation in mesenchymal cells.
    Tang L; Ebara S; Kawasaki S; Wakabayashi S; Nikaido T; Takaoka K
    Cell Biol Int; 2002; 26(1):75-84. PubMed ID: 11779223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomineral/Agarose Composite Gels Enhance Proliferation of Mesenchymal Stem Cells with Osteogenic Capability.
    Suzawa Y; Kubo N; Iwai S; Yura Y; Ohgushi H; Akashi M
    Int J Mol Sci; 2015 Jun; 16(6):14245-58. PubMed ID: 26110392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenic phenotype expression of allogeneic rat marrow cells in porous hydroxyapatite ceramics.
    Akahane M; Ohgushi H; Yoshikawa T; Sempuku T; Tamai S; Tabata S; Dohi Y
    J Bone Miner Res; 1999 Apr; 14(4):561-8. PubMed ID: 10234577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed electromagnetic fields stimulate osteogenic differentiation in human bone marrow and adipose tissue derived mesenchymal stem cells.
    Ongaro A; Pellati A; Bagheri L; Fortini C; Setti S; De Mattei M
    Bioelectromagnetics; 2014 Sep; 35(6):426-36. PubMed ID: 25099126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EXPERIMENTAL STUDY ON OSTEOGENESIS OF SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS IN VITRO AND IN VIVO].
    Zheng W; Yang M; Wu C; Su X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Jan; 30(1):102-9. PubMed ID: 27062856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simvastatin on the osteogenic differentiation and immunomodulation of bone marrow mesenchymal stem cells.
    Niu J; Ding G; Zhang L
    Mol Med Rep; 2015 Dec; 12(6):8237-40. PubMed ID: 26499955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived mesenchymal cells can rescue osteogenic capacity of devitalized autologous bone.
    Tohma Y; Ohgushi H; Morishita T; Dohi Y; Tadokoro M; Tanaka Y; Takakura Y
    J Tissue Eng Regen Med; 2008 Jan; 2(1):61-8. PubMed ID: 18361480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myricetin enhances osteogenic differentiation through the activation of canonical Wnt/β-catenin signaling in human bone marrow stromal cells.
    Ying X; Chen X; Feng Y; Xu HZ; Chen H; Yu K; Cheng S; Peng L
    Eur J Pharmacol; 2014 Sep; 738():22-30. PubMed ID: 24876056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells.
    Both SK; van Apeldoorn AA; Jukes JM; Englund MC; Hyllner J; van Blitterswijk CA; de Boer J
    J Tissue Eng Regen Med; 2011 Mar; 5(3):180-90. PubMed ID: 20718035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells.
    Gong Z; Wezeman FH
    Alcohol Clin Exp Res; 2004 Mar; 28(3):468-79. PubMed ID: 15084905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing In Vitro Osteogenesis in Canine Autologous and Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells with Dexamethasone and BMP-2.
    Gasson SB; Dobson LK; Chow L; Dow S; Gregory CA; Saunders WB
    Stem Cells Dev; 2021 Feb; 30(4):214-226. PubMed ID: 33356875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.